ANALYSIS: How GSK’s Canada SC hearing unfolded
January 17, 2012
Sophie Ashley - TPW
The Supreme Court of Canada met last week to hear the Canada Revenue Agency's (CRA) appeal and GlaxoSmithKline’s (GSK) response in a case about whether the taxpayer paid too much for active pharmaceutical ingredients (API) from a Swiss associated enterprise.
Sorry. You must be a subscriber to view this article. Alternatively, why not take a free trial? To subscribe and access this article immediately simply click here or call +44(0)207 779 8380.